Y. Ogata

1.3k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Y. Ogata is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Y. Ogata has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Y. Ogata's work include Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (9 papers) and Colorectal Cancer Surgical Treatments (7 papers). Y. Ogata is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (9 papers) and Colorectal Cancer Surgical Treatments (7 papers). Y. Ogata collaborates with scholars based in Japan, United States and United Kingdom. Y. Ogata's co-authors include Hideaki Nagase, Jan J. Enghild, T. Morodomi, Minoru Morimatsu, Yasuyuki Sasaguri, Kazuo Shirouzu, David E. Woolley, Hiroyuki Nagase, P. Bischof and Yoshifumi Itoh and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Y. Ogata

30 papers receiving 1.1k citations

Hit Papers

Matrix metalloproteinase 3 (stromelysin) activates the pr... 1992 2026 2003 2014 1992 100 200 300 400 500

Peers

Y. Ogata
Teresa I. Mitchell United States
Giovanna Butticè United States
Timothy E. Cawston United Kingdom
Cathleen Conner United States
Jill D. Roby United States
Michelle Drews United States
Teresa I. Mitchell United States
Y. Ogata
Citations per year, relative to Y. Ogata Y. Ogata (= 1×) peers Teresa I. Mitchell

Countries citing papers authored by Y. Ogata

Since Specialization
Citations

This map shows the geographic impact of Y. Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Ogata more than expected).

Fields of papers citing papers by Y. Ogata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Ogata. The network helps show where Y. Ogata may publish in the future.

Co-authorship network of co-authors of Y. Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Ogata. A scholar is included among the top collaborators of Y. Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Ogata. Y. Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takazono, Takahiro, Shotaro Ide, Y. Ogata, et al.. (2025). Risk Factors and Prognostic Effects of Aspergillosis as a Complication of Nontuberculous Mycobacterial Pulmonary Disease: A Nested Case–Control Study. Mycoses. 68(1). e70022–e70022. 2 indexed citations
2.
Mwakawanga, Dorkasi L., Sanmei Chen, Y. Ogata, et al.. (2024). Barriers and facilitators of fetal heart monitoring with a mobile cardiotocograph (iCTG) device in underserved settings: An exploratory qualitative study from Tanzania. PLoS ONE. 19(12). e0314812–e0314812. 1 indexed citations
3.
Takahashi, Tsuyoshi, Sotaro Sadahiro, Kazuhiro Sakamoto, et al.. (2020). 408P A prospective controlled trial of the efficacy of uracil and tegafur/leucovorin for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201). Annals of Oncology. 31. S414–S415. 1 indexed citations
4.
Yamaguchi, Shigeki, Katsuyuki Kunieda, Masaaki Kobayashi, et al.. (2016). Phase III trial of 24 weeks vs. 48 weeks capecitabine adjuvant chemotherapy for patients with stage III colon cancer: Final results of JFMC37-0801. Annals of Oncology. 27. vi155–vi155. 2 indexed citations
5.
Takatsuki, Mitsuhisa, Shusaku Uchida, Masahiko Sakoda, et al.. (2015). Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study. European Journal of Surgical Oncology. 42(2). 184–189. 8 indexed citations
6.
Takada, Satoshi, Homare Ito, Yohei Masugi, et al.. (2014). Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature. Japanese Journal of Clinical Oncology. 45(3). 286–290. 7 indexed citations
7.
Imai, Katsunori, Yasunori Emi, Toru Beppu, et al.. (2013). Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome. European Journal of Surgical Oncology. 40(5). 559–566. 43 indexed citations
8.
Yamaguchi, Rin, Maki Tanaka, Kazuhiro Kondo, et al.. (2010). Characteristic Morphology of Invasive Micropapillary Carcinoma of the Breast: An Immunohistochemical Analysis. Japanese Journal of Clinical Oncology. 40(8). 781–787. 25 indexed citations
9.
Shirouzu, Kazuo, et al.. (2006). High-quality Follow-up System for Colorectal Cancer-A Computer Registration and Administration System-. Nihon Daicho Komonbyo Gakkai Zasshi. 59(10). 869–873.
10.
Tomita, Naohiro, Masahiko Watanabe, Masao Kameyama, et al.. (2005). Questionnaire Survey on Very Low Resection with Peranal Coloanal Anastomosis for Lower Rectal Cancer. Nihon Daicho Komonbyo Gakkai Zasshi. 58(1). 1–12. 1 indexed citations
11.
Shirouzu, Kazuo, Y. Ogata, Yasumi Araki, Yui Kishimoto, & Yuichiro Sato. (2003). A new ultimate anus-preserving operation for extremely low rectal cancer and for anal canal cancer. Techniques in Coloproctology. 7(3). 203–206. 29 indexed citations
13.
Jeziorska, Maria, Najib Haboubi, P F Schofield, et al.. (1994). Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. International Journal of Colorectal Disease. 9(3). 141–148. 32 indexed citations
14.
Shirouzu, Kazuo, et al.. (1994). A Case of Radiation-induced Rectal Cancer Developing after a Long-term Follow-up. Japanese Journal of Clinical Oncology. 24(5). 294–8. 1 indexed citations
15.
Sakaguchi, K., Masakazu Suzuki, Y. Ogata, Kazuhiro Suzuki, & Tetsu Kamitani. (1993). Biodistribution of the neo red cell and effect on the phagocytic activity of the reticuloendothelial system. 22(2). 560–565. 2 indexed citations
16.
Tetlow, L. C., et al.. (1993). Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatology International. 13(2). 53–59. 65 indexed citations
17.
Morodomi, T., Y. Ogata, Yasuyuki Sasaguri, Minoru Morimatsu, & Hideaki Nagase. (1992). Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochemical Journal. 285(2). 603–611. 173 indexed citations
18.
Shirouzu, Kazuo, Hiroharu Isomoto, T. Morodomi, et al.. (1992). Significance of Histomorphological Heterogeneity of Colorectal Cancer.. Nihon Daicho Komonbyo Gakkai Zasshi. 45(6). 855–862. 1 indexed citations
19.
Fujiyoshi, Mary Raina Angeli, Hiroharu Isomoto, Kazuo Shirouzu, et al.. (1991). Clinicopathological Study and the Therapeutic Plan of Early Colorectal Cancer.. Nihon Daicho Komonbyo Gakkai Zasshi. 44(4). 415–425. 1 indexed citations
20.
Maekawa, Masato, Y. Ogata, C Kawai, et al.. (1960). Studies on Pulmonary Circulation. Part 2. Pulmonary Capillary and Pulmonary Arterial Pressures, and Findings of Biopsy of the Lung in Mitral Valvular Disease(Proceedings of the 24th Annual Meeting The Japanese Circulation Society [Part II]). Japanese Circulation Journal-english Edition. 24(10). 1212–1213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026